Literature DB >> 17611054

Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.

Ashwin Basarkar1, Dilip Devineni, Ravi Palaniappan, Jagdish Singh.   

Abstract

The objective of this study was to investigate the effect of formulation parameters (i.e. polymer molecular weight and homogenization speed) on various physicochemical and biological properties of cationic nanoparticles. Cationic nanoparticles were prepared using different molecular weights of poly(DL-lactide-co-glycolide) (PLGA) and poly(DL-lactic acid) (PLA) by double emulsion solvent evaporation at two different homogenization speeds, and were characterized in terms of size, surface charge, morphology, loading efficiency, plasmid release, plasmid integrity, cytotoxicity, and transfection efficiency. Cationic surfactant, cetyltrimethylammonium bromide (CTAB), was used to provide positive charge on the surface of nanoparticles. Reporter plasmid gWIZ Beta-gal was loaded on the surface of nanoparticles by incubation. Use of higher homogenization speed and lower molecular weight polymer led to a decrease in mean particle size, increase in zeta potential, increase in plasmid loading efficiency, and a decrease in burst release. The nanoparticles displayed good morphology as evident from scanning electron micrographs. In vitro cytotoxicity study by MTT assay showed a low toxicity. Structural integrity of the pDNA released from nanoparticles was maintained. Transfecting human embryonic kidney (HEK293) cells with nanoparticles prepared from low molecular weight PLGA and PLA resulted in an increased expression of beta-galactosidase as compared to those prepared from high molecular weight polymer. Our results demonstrate that the PLGA and PLA cationic nanoparticles can be used to achieve prolonged release of pDNA, and the plasmid release rate and transfection efficiency are dependent on the formulation variables.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611054      PMCID: PMC6186392          DOI: 10.1016/j.ijpharm.2007.05.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  34 in total

1.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

Authors:  E Walter; K Moelling; J Pavlovic; H P Merkle
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

2.  Cationic microparticles are a potent delivery system for a HCV DNA vaccine.

Authors:  Derek T O'Hagan; Manmohan Singh; Christine Dong; Mildred Ugozzoli; Kim Berger; Edward Glazer; Mark Selby; Mark Wininger; Philip Ng; Kevin Crawford; Xavier Paliard; Steven Coates; Michael Houghton
Journal:  Vaccine       Date:  2004-12-16       Impact factor: 3.641

Review 3.  Gene therapy for severe combined immunodeficiency.

Authors:  Marina Cavazzana-Calvo; Chantal Lagresle; Salima Hacein-Bey-Abina; Alain Fischer
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

Review 4.  Advances in cystic fibrosis gene therapy.

Authors:  Uta Griesenbach; Duncan M Geddes; Eric W F W Alton
Journal:  Curr Opin Pulm Med       Date:  2004-11       Impact factor: 3.155

Review 5.  Non-viral delivery of ribozymes for cancer gene therapy.

Authors:  Mohammed Kashani-Sabet
Journal:  Expert Opin Biol Ther       Date:  2004-11       Impact factor: 4.388

6.  Intracellular uptake and release of poly(ethyleneimine)-co-poly(methyl methacrylate) nanoparticle/pDNA complexes for gene delivery.

Authors:  Min Feng; Daniel Lee; Pei Li
Journal:  Int J Pharm       Date:  2006-01-25       Impact factor: 5.875

7.  Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier.

Authors:  In-Sook Kim; Soo-Kyung Lee; Yu-Mi Park; Yong-Bok Lee; Sang-Chul Shin; Kang Choon Lee; In-Joon Oh
Journal:  Int J Pharm       Date:  2005-07-14       Impact factor: 5.875

8.  Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.

Authors:  Sudhir P Kasturi; Karishma Sachaphibulkij; Krishnendu Roy
Journal:  Biomaterials       Date:  2005-11       Impact factor: 12.479

9.  Preparation and characterization of cationic microspheres for gene delivery.

Authors:  E Esposito; S Sebben; R Cortesi; E Menegatti; C Nastruzzi
Journal:  Int J Pharm       Date:  1999-10-28       Impact factor: 5.875

10.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  22 in total

Review 1.  Targeted delivery with peptidomimetic conjugated self-assembled nanoparticles.

Authors:  Esmaiel Jabbari
Journal:  Pharm Res       Date:  2008-12-17       Impact factor: 4.200

2.  Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles.

Authors:  Esmaiel Jabbari; Xiaoming Yang; Seyedsina Moeinzadeh; Xuezhong He
Journal:  Eur J Pharm Biopharm       Date:  2012-12-27       Impact factor: 5.571

Review 3.  Polymeric vectors for ocular gene delivery.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitrat
Journal:  Ther Deliv       Date:  2011-04

4.  Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine.

Authors:  Yanwei Sun; Yang Zhang; Ci Shi; Wei Li; Gang Chen; Xiaohua Wang; Kai Zhao
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.

Authors:  Weiwei Zou; Chunxi Liu; Zhijin Chen; Na Zhang
Journal:  Nanoscale Res Lett       Date:  2009-05-21       Impact factor: 4.703

6.  New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.

Authors:  Jian-Ming Lü; Zhengdong Liang; Xiaoxiao Wang; Jianhua Gu; Qizhi Yao; Changyi Chen
Journal:  Nanomedicine (Lond)       Date:  2016-07-26       Impact factor: 5.307

Review 7.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

Review 8.  PLA micro- and nano-particles.

Authors:  Byung Kook Lee; Yeonhee Yun; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2016-06-01       Impact factor: 15.470

9.  Polymeric nanoparticles for siRNA delivery and gene silencing.

Authors:  Yogesh Patil; Jayanth Panyam
Journal:  Int J Pharm       Date:  2008-10-01       Impact factor: 5.875

10.  Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.

Authors:  Biswajit Mukherjee; Kousik Santra; Gurudutta Pattnaik; Soma Ghosh
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.